期刊文献+

1例犬肥大细胞瘤的诊治

Diagnosis and treatment of a canine mastocytoma
下载PDF
导出
摘要 文章报告一例患有肥大细胞瘤的雌性老龄犬的诊断、治疗过程。通过临床检查、血液生化检查、细胞学检查、影像学检查以及病理组织学检查对患犬的情况进行全面评估。采用手术治疗方法,包括肿瘤摘除和脾脏摘除。术后患犬愈合良好,无明显不良反应。结果提示,犬肥大细胞瘤的诊断和治疗需要综合多种方法,包括临床检查、实验室检查和手术治疗。早期诊断和综合治疗可改善患犬的预后,并降低复发率。同时,宠主应关注宠物的生活环境和生活习惯,以降低患病风险。 The paper reports the diagnosis and treatment of a old female canine with mastocytoma.The conditions of the canine were evaluated comprehensively by clinical examination,blood biochemical examination,cytological examination,imaging examination,and histopathological examination.Surgical treatment was used,including tumor removal and splenectomy.The canine healed well after operation without obvious adverse reactions.The results suggest that the diagnosis and treatment of canine mastocytoma requires a combination of various methods,including clinical examination,laboratory examination and surgical treatment.Early diagnosis and comprehensive treatment can improve the prognosis of dogs and reduce the recurrence rate.At the same time,pet owners should pay attention to the living environment and habits of pets to reduce the risk of illness.
作者 徐茂森 赵燕 贺闪闪 李龙娇 张利 Xu Maosen;Zhao Yan;He Shanshan;Li Longjiao;Zhang Li(Chongqing Three Gorges Vocational College,Chongqing 404155;Chongqing Animal Disease Prevention and Control Center,Chongqing 401120)
出处 《现代畜牧兽医》 2024年第2期57-61,共5页 Modern Journal of Animal Husbandry and Veterinary Medicine
基金 重庆市教育委员会科研基金(KJQN202003503)。
关键词 肥大细胞瘤 肿瘤 肿瘤转移 Canine Mastocytoma Tumor Tumor metastasis
  • 相关文献

参考文献8

二级参考文献53

  • 1吴贤杰,郑敏.肥大细胞增生症与干细胞因子受体(c-kit)突变的关系[J].国外医学(生理病理科学与临床分册),2005,25(1):87-90. 被引量:8
  • 2Longley BJ, Reguera MJ, Ma Y. Classes of c-kit activating mutations: proposed mechanisms of action and implications for disease classification and therapy [ J ]. Leuk Res, 2001, 25 (7) : 571-576. 被引量:1
  • 3Chan PM, Ilangumaran S, La Rose J, et al. Autoinhibition of the kit receptor tyrosine kinase by the cytosolic juxtamembrane region [ J ].Mol Cell Biol, 2003, 23 (9) : 3067-3078. 被引量:1
  • 4Hashimoto K, Matsumura I, Tsujimura T, et al. Necessity of tyrosine 719 and phosphatidylinositol 3 '-kinase-mediated signal pathway in constitutive activation and oncogenic potential of c-kit receptor tyrosine kinase with the Asp814Val mutation[J]. Blood, 2003, 101(3) : 1094-1102. 被引量:1
  • 5Piao X, Paulson R, van der Geer P, et al. Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1 [ J ].Proc Natl Acad Sci USA, 1996, 93(25) : 14665-14669. 被引量:1
  • 6Shivakrupa R, Bemstein A, Watring N, et al. Tidylinositol 3'-kinaseis required for growth of mast cells expressing the kit catalytic domain mutant[J]. Cancer Res, 2003, 63(15) : 4412-4419. 被引量:1
  • 7Chian R, Young S, Danilkovitch-Miagkova A, et al. Phosphatidylinositol 3 kinase contributes to the transformation of hematopoietic cells by the D816V c-kit mutant[J]. Blood, 2001, 98(5) : 1365-1373. 被引量:1
  • 8Ning ZQ, Li J, McGuinness M, et al. STAT3 activation is required for Asp(816) mutant c-kit induced tumorigenicity [ J ]. Oncogene,2001,20(33 ) : 4528-4536. 被引量:1
  • 9Taylor ML, Dastych J, Sehgal D, et al. The Kit-activating mutation D816V enhances stem cell factor-dependent chemotaxis [ J ].Blood, 2001, 98(4) : 1195-1199. 被引量:1
  • 10Akin C, Kirshenbaum AS, Semere T, et al. Analysis of the surface expression of and myelomonocytic cells in patients with mastocytosis[J]. Exp Hematol, 2000, 28(2) : 140-147. 被引量:1

共引文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部